64 2023 sicily English-speaking jobs in Emilia-Romagna

Headquartered in Dallas, Celanese employs approximately 13,000 employees worldwide, with 2023 net sales

In 2023, the technology group with its approximately 72,500 employees, generated sales of just under ... In 2023, the business unit recorded a sales volume of more than EUR 1.25 billion globally (as of 31.12.2023

Coesia operates in 36 countries with 20 different companies and employs over 8,000 people as of 2023.

Consolidated Financial Results as of June 30, 2023.

Coesia operates in 36 countries with 20 different companies and employs over 8,000 people as of 2023.

Coesia operates in 36 countries with 20 different companies and employs over 8,000 people as of 2023.

Launched in October 2023, Farmfront Group is Europe’s irrigation expert and a leading global platform

Coesia operates in 36 countries with 20 different companies and employs over 8,000 people as of 2023.

Allegion plc, 2023 | Block D, Iveagh Court, Harcourt Road, Dublin 2, Co.

In 2023, the group reported global sales of SEK 12bn and employed approximately 4,300 people.

Consolidated Financial Results at June 30, 2023 Webuild is hiring a Commercial Planning & Market Analysis

Since 2023, Fondazione Telethon is also the holder of marketing authorization in Europe for Strimvelis

Awards Recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023

Awards Recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023

Awards Recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023

In 2023, Future Electronics announced a strategic partnership with WT Microelectronics to deliver sustainable

and as the World's Best Independent Hotel PMS Provider 2022 and 2023 by the World Travel Tech Awards ... achievements don't stop there; Mews was also listed among the World's Best Hotel PMS Provider 2023

Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority ... strong launch in February to the US market with the EMA review process concluded positively in September 2023

Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority ... strong launch in February to the US market with the EMA review process concluded positively in September 2023

Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority ... strong launch in February to the US market with the EMA review process concluded positively in September 2023